Codagenix
Codagenix Inc., based in Cambridge, MA, is pioneering innovative solutions in global health through the engineering of viruses. By combining live-attenuated virus design with advanced codon deoptimization technology, they are creating a robust synthetic biology platform to address significant challenges in infectious diseases and cancer.
With a focus on delivering timely vaccines and novel cancer therapies, Codagenix employs a proprietary approach that integrates precise edits into viral genomes, ensuring broad immunity, enhanced safety, and scalability. The company's efforts extend to improving animal health, contributing to a healthier planet overall.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
